We are pleased to announce that Exploration of Neuroprotective Therapy (ENT) has achieved a CiteScore of 2.6 for 2025, up from 2.0 last year, as recently released by Scopus.

Scopus Page of ENT Journal: https://www.scopus.com/sourceid/21101256286

CiteScore™ 2025: 2.6

This notable increase reflects the growing recognition of the journal within the neuroscience and neuroprotection research communities, underscoring the quality, relevance, and impact of the work published in ENT. It also highlights the collective dedication of our Editor-in-Chief, editorial board members, authors, reviewers, and readers.

Over the past years, the journal has remained committed to rigorous peer review, timely publication, and the advancement of innovative research in neuroprotection, neurodegenerative diseases, neurorestoration, and related areas.

While celebrating this achievement, ENT continues to strive for excellence. We remain dedicated to fostering high-quality research and contributing further to the advancement of neuroscience.

We sincerely thank everyone who has contributed to this progress. Together, we will continue to grow and strengthen ENT as a trusted and impactful platform in the field.